NEU 2.50% $15.59 neuren pharmaceuticals limited

Ann: Neuren to capture substantially greater value after Phase 3, page-48

  1. 11,703 Posts.
    lightbulb Created with Sketch. 1690
    The thing is, it's obvious that a deal post successful phase 3 will be worth more. But the ann almost makes it sound like a revelation! After months of work, Torreya have come up with the bleeding obvious!

    The down side of course is we carry a bit more risk.

    Personally I don't mind, but I've taken good profits in the past and am free carried. The person who bought at $3 a few weeks ago might not be so pleased!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.